Long-Term Follow-Up of Allogeneic Marrow Transplants in Patients With Aplastic Anemia Conditioned by Cyclophosphamide Combined With Antithymocyte Globulin
- 15 May 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 89 (10), 3890
- https://doi.org/10.1182/blood.v89.10.3890
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemiaBlood, 1994
- Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulinBlood, 1987
- Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host diseaseBlood, 1986
- Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical SiblingsAnnals of Internal Medicine, 1983
- Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patientsBlood, 1982
- Effect of Prior Blood Transfusions on Marrow Grafts: Abrogation of Sensitization by Procarbazine and Antithymocyte SerumThe Journal of Immunology, 1974